$2.35T
Total marketcap
$109.32B
Total volume
BTC 50.74%     ETH 15.63%
Dominance

Concord Medical Services Holdings Limited C2CA.F Stock

0.56 EUR {{ price }} -1.754384% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
25.5M EUR
LOW - HIGH [24H]
0.56 - 0.56 EUR
VOLUME [24H]
500 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-1.38 EUR

Concord Medical Services Holdings Limited Price Chart

Concord Medical Services Holdings Limited C2CA.F Financial and Trading Overview

Concord Medical Services Holdings Limited stock price 0.56 EUR
Previous Close 1.25 EUR
Open 1.21 EUR
Bid 1.21 EUR x 100000
Ask 1.29 EUR x 100000
Day's Range 1.21 - 1.21 EUR
52 Week Range 0.94 - 1.98 EUR
Volume 500 EUR
Avg. Volume 0 EUR
Market Cap 57.36M EUR
Beta (5Y Monthly) -0.232042
PE Ratio (TTM) N/A
EPS (TTM) -1.38 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date December 23, 2015
1y Target Est N/A

C2CA.F Valuation Measures

Enterprise Value 7.01B EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.1215034
Price/Book (mrq) N/A
Enterprise Value/Revenue 14.854
Enterprise Value/EBITDA -17.45

Trading Information

Concord Medical Services Holdings Limited Stock Price History

Beta (5Y Monthly) -0.232042
52-Week Change -29.76%
S&P500 52-Week Change 20.43%
52 Week High 1.98 EUR
52 Week Low 0.94 EUR
50-Day Moving Average 1.19 EUR
200-Day Moving Average 1.39 EUR

C2CA.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 43.42M
Float 13.3M
Short Ratio N/A
% Held by Insiders 17.99%
% Held by Institutions 0.37%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -103.72%
Operating Margin (ttm) -111.21%
Gross Margin -32.28%
EBITDA Margin -85.12%

Management Effectiveness

Return on Assets (ttm) -5.36%
Return on Equity (ttm) -32.31%

Income Statement

Revenue (ttm) 472.08M EUR
Revenue Per Share (ttm) 10.81 EUR
Quarterly Revenue Growth (yoy) 12.00%
Gross Profit (ttm) -152409000 EUR
EBITDA -401860992 EUR
Net Income Avi to Common (ttm) -489660992 EUR
Diluted EPS (ttm) -1.37
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 158.28M EUR
Total Cash Per Share (mrq) 3.65 EUR
Total Debt (mrq) 3.24B EUR
Total Debt/Equity (mrq) 160.74 EUR
Current Ratio (mrq) 0.678
Book Value Per Share (mrq) -42.931

Cash Flow Statement

Operating Cash Flow (ttm) -216694000 EUR
Levered Free Cash Flow (ttm) -747450112 EUR

Profile of Concord Medical Services Holdings Limited

Country Germany
State N/A
City Beijing
Address Tower A, Global Trade Center
ZIP 100013
Phone 86 10 5903 6688
Website https://www.concordmedical.com
Industry Medical Care Facilities
Sector(s) Healthcare
Full Time Employees 918

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, head gamma knife system, and diagnostic imaging services. The company's other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Q&A For Concord Medical Services Holdings Limited Stock

What is a current C2CA.F stock price?

Concord Medical Services Holdings Limited C2CA.F stock price today per share is 0.56 EUR.

How to purchase Concord Medical Services Holdings Limited stock?

You can buy C2CA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Concord Medical Services Holdings Limited?

The stock symbol or ticker of Concord Medical Services Holdings Limited is C2CA.F.

Which industry does the Concord Medical Services Holdings Limited company belong to?

The Concord Medical Services Holdings Limited industry is Medical Care Facilities.

How many shares does Concord Medical Services Holdings Limited have in circulation?

The max supply of Concord Medical Services Holdings Limited shares is 45.54M.

What is Concord Medical Services Holdings Limited Price to Earnings Ratio (PE Ratio)?

Concord Medical Services Holdings Limited PE Ratio is now.

What was Concord Medical Services Holdings Limited earnings per share over the trailing 12 months (TTM)?

Concord Medical Services Holdings Limited EPS is -1.38 EUR over the trailing 12 months.

Which sector does the Concord Medical Services Holdings Limited company belong to?

The Concord Medical Services Holdings Limited sector is Healthcare.